Tinea Versicolor Clinical Trial
Official title:
Clinical Evaluation of a Formulated Nanoemulsion for Topical Application
Verified date | September 2019 |
Source | Minia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Clinical study for the developed voriconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.
Status | Completed |
Enrollment | 30 |
Est. completion date | June 30, 2018 |
Est. primary completion date | June 20, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Tinea Versicolor infection Exclusion Criteria: - concomitant treatment with other medications for the same condition being studied, TVC. - pregnancy - lactation - immunocompromised patients |
Country | Name | City | State |
---|---|---|---|
Egypt | Minia University hospital | Minya | Minia |
Lead Sponsor | Collaborator |
---|---|
Sara Botros |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | complete cure | 1-4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00830388 -
Ketoconazole Foam 2% for the Treatment of Versicolor
|
Phase 4 | |
Completed |
NCT04937920 -
A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
|
Phase 2 | |
Completed |
NCT05862714 -
Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor
|
Phase 1 | |
Not yet recruiting |
NCT05730244 -
A Study of the Clinical Efficacy and Safety of 100% Cassia Alata Extract Against Tinea Versicolor
|
Phase 1 | |
Completed |
NCT04110834 -
Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
|
Phase 2 | |
Completed |
NCT06305637 -
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
|
Phase 1 |